Passage Bio Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 08/14/2026 | 2.89 M | $4.31 M | 100.00% | 89.95% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 673.76 K | $3.29 M | 8.03% | 21.00% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 113.96 K | $556.14 K | 0.00% | 3.55% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 107.03 K | $522.28 K | 100.00% | 3.34% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 99.52 K | $485.64 K | 46.08% | 3.10% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 86.10 K | $420.15 K | 0.00% | 2.68% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 47.89 K | $233.71 K | -64.16% | 1.49% |
| ERSTE ASSET MANAGEMENT GMBH | 07/28/2026 | 40.67 K | $197.23 K | -52.31% | 1.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 37.03 K | $180.72 K | -10.52% | 1.15% |
| VERDAD ADVISERS, LP | 08/14/2026 | 30.73 K | $149.95 K | 38.86% | 0.96% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 28.44 K | $138.78 K | 50.70% | 0.89% |
| BLACKROCK, INC. | 08/07/2026 | 27.91 K | $136.20 K | -2.40% | 0.87% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 22.50 K | $109.00 K | -7.03% | 0.70% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 17.05 K | $83.20 K | 0.00% | 0.53% |
| DELTEC ASSET MANAGEMENT LLC | 07/21/2026 | 15.00 K | $73.20 K | 100.00% | 0.47% |
| UBS GROUP AG | 08/13/2026 | 13.57 K | $66.20 K | -50.67% | 0.42% |
| HRT FINANCIAL LP | 08/14/2026 | 12.71 K | $62.00 K | 100.00% | 0.40% |
| FIDUCIARY TRUST CO | 08/13/2026 | 10.75 K | $52.46 K | 0.00% | 0.34% |
| GTS SECURITIES LLC | 08/14/2026 | 10.00 K | $48.80 K | 100.00% | 0.31% |
| MORGAN STANLEY | 08/13/2026 | 2.39 K | $11.66 K | -9.85% | 0.07% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 638 | $3.11 K | 0.00% | 0.02% |
| BARCLAYS PLC | 08/14/2026 | 212 | $1.04 K | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 169 | $825 | 36.29% | 0.01% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 115 | $561 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 15 | $73 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 15 | $73 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 12 | $59 | 0.00% | 0.00% |
| LRI INVESTMENTS, LLC | 07/14/2026 | 12 | $59 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 08/12/2026 | 3 | $15 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| DIADEMA PARTNERS LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| PERSISTENT ASSET PARTNERS LTD | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Passage Bio Inc institutional Ownership - FAQ's
During the previous two years, 50 institutional investors and hedge funds held shares of Passage Bio Inc. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 2.89 M
Lynx1 Capital Management LP: 673,759
VANGUARD CAPITAL MANAGEMENT LLC: 113,964
BALYASNY ASSET MANAGEMENT L.P.: 107,025
Ikarian Capital, LLC: 99,517
Yiheng Capital Management, L.P.: 86,097
133.52% of Passage Bio Inc stock is owned by institutional investors.
Institutional investors have bought a total of 7.04 M shares in the last 24 months. This purchase volume represents approximately $61.91 M in transactions.